399 related articles for article (PubMed ID: 12967592)
41. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis.
Deleuze JF; Jacquemin E; Dubuisson C; Cresteil D; Dumont M; Erlinger S; Bernard O; Hadchouel M
Hepatology; 1996 Apr; 23(4):904-8. PubMed ID: 8666348
[TBL] [Abstract][Full Text] [Related]
42. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
[TBL] [Abstract][Full Text] [Related]
43. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
[TBL] [Abstract][Full Text] [Related]
44. [Childhood cholestasis and bile transporters].
Hierro L; Jara P
Gastroenterol Hepatol; 2005; 28(7):388-95. PubMed ID: 16137474
[TBL] [Abstract][Full Text] [Related]
45. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
[TBL] [Abstract][Full Text] [Related]
46. Appearance of atypical 3 alpha,6 beta,7 beta,12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid in spgp knockout mice.
Perwaiz S; Forrest D; Mignault D; Tuchweber B; Phillip MJ; Wang R; Ling V; Yousef IM
J Lipid Res; 2003 Mar; 44(3):494-502. PubMed ID: 12562825
[TBL] [Abstract][Full Text] [Related]
47. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Weiglein AH; Lammert F; Marschall HU; Tsybrovskyy O; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2002 Oct; 123(4):1238-51. PubMed ID: 12360485
[TBL] [Abstract][Full Text] [Related]
48. Liver diseases related to MDR3 (ABCB4) gene deficiency.
Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
[TBL] [Abstract][Full Text] [Related]
49. ABCG5/ABCG8-independent biliary cholesterol excretion in lactating rats.
Coy DJ; Wooton-Kee CR; Yan B; Sabeva N; Su K; Graf G; Vore M
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G228-35. PubMed ID: 20413720
[TBL] [Abstract][Full Text] [Related]
50. 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps.
Hayashi H; Sugiyama Y
Hepatology; 2007 Jun; 45(6):1506-16. PubMed ID: 17538928
[TBL] [Abstract][Full Text] [Related]
51. ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile.
Langheim S; Yu L; von Bergmann K; Lütjohann D; Xu F; Hobbs HH; Cohen JC
J Lipid Res; 2005 Aug; 46(8):1732-8. PubMed ID: 15930516
[TBL] [Abstract][Full Text] [Related]
52. Evolving concepts in the pathophysiology of biliary lipid secretion.
Carrella M; Roda E
Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):643-8. PubMed ID: 10604109
[TBL] [Abstract][Full Text] [Related]
53. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
54. Regulation of mdr2 P-glycoprotein expression by bile salts.
Frijters CM; Ottenhoff R; van Wijland MJ; van Nieuwkerk CM; Groen AK; Oude Elferink RP
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):389-95. PubMed ID: 9020871
[TBL] [Abstract][Full Text] [Related]
55. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
56. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver.
Gerloff T; Stieger B; Hagenbuch B; Madon J; Landmann L; Roth J; Hofmann AF; Meier PJ
J Biol Chem; 1998 Apr; 273(16):10046-50. PubMed ID: 9545351
[TBL] [Abstract][Full Text] [Related]
57. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats.
Hooiveld GJ; Vos TA; Scheffer GL; Van Goor H; Koning H; Bloks V; Loot AE; Meijer DK; Jansen PL; Kuipers F; Müller M
Gastroenterology; 1999 Sep; 117(3):678-87. PubMed ID: 10464145
[TBL] [Abstract][Full Text] [Related]
58. Cholestatic effects of cyclosporine in the rat.
Chan FK; Shaffer EA
Transplantation; 1997 Jun; 63(11):1574-8. PubMed ID: 9197348
[TBL] [Abstract][Full Text] [Related]
59. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein.
Oude Elferink RP; Ottenhoff R; van Wijland M; Frijters CM; van Nieuwkerk C; Groen AK
J Lipid Res; 1996 May; 37(5):1065-75. PubMed ID: 8725158
[TBL] [Abstract][Full Text] [Related]
60. Transporters on demand: intrahepatic pools of canalicular ATP binding cassette transporters in rat liver.
Kipp H; Pichetshote N; Arias IM
J Biol Chem; 2001 Mar; 276(10):7218-24. PubMed ID: 11113123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
